Montana Lara accepted as ASHG scholar
Dr. Montana Lara was selected to be a scholar in the Human Genetics Scholars Initiative program from the American Society of Human Genetics (ASHG).
Congratulations!
Dr. Montana Lara was selected to be a scholar in the Human Genetics Scholars Initiative program from the American Society of Human Genetics (ASHG).
Congratulations!
The manuscript titled “Data-driven RNA phenotyping captures genetically regulated dimensions of the transcriptome” was accepted for publication in the American Journal of Human Genetics.
Authors include current Palmer Lab members Daniel Munro and Abraham Palmer.
Congratulations!
Dr. Palmer gave a talk during the 49th Annual Scientific Meeting of the Research Society on Alcohol (RSA) on June 21, 2026 in San Antonio, Texas.
Dr. Palmer’s talk, “Using every part of the buffalo: how a large rodent genetics project encouraged spinoffs, collaborations and secondary data analyses,” was part of the round table session titled “From Biobanks to Behavior: How Shared Bioresources and Genetic Pipelines Drive Ethical Innovation in Preclinical Alcohol Research.”
Dr. Palmer gave a talk during the Annual Meeting of the College on Problems of Drug Dependence (CPDD) on June 17, 2026 in Portland, Oregon.
Dr. Palmer’s talk, “How it Begins: Initial Response to Opioids Strongly Predicts Self-Reported Opioid Use Disorder,” was part of the symposium session titled “Opioid Sensitivity as a Testable Behavioral Phenotype for Extramedical Opioid Use,” organized by Kelly Dunn.
Dr. Montana Lara was invited to give a talk at N@N—Neuroscience at Nemours—on June 17, 2026.
Dr. Lara’s talk, “Decoding complex neurobehavioral traits using multivariate genomic approaches” was hosted by Nemours Children’s Hospital and the University of Delaware.
Dr. Palmer gave a talk during the Population, Evolutionary, and Quantitative Genetics Conference (PEQG)
on June 11, 2026 at the Asilomar Conference Grounds in Pacific Grove, California.
His talk was titled “The Center for Genetics, Genomics, and Epigenetics of Substance Use Disorders in Outbred Rats.”
Dr. Daniel Munro, Assistant Project Scientist at Palmer Lab, was awarded a Pilot Grant for his project titled “Mapping Protein Quantitative Trait Loci in the Heterogeneous Stock Rat Brain to Identify Causal Genes at Substance Use Disorder GWAS Loci.”
Congratulations!
Dr. Palmer presented a poster at the annual NIDA Genetics and Epigenetics Cross-Cutting Research Team Meeting on June 5, 2026 at NIH in Bethesda, Maryland. His presentation was titled “The thrill is gone — or is it? Insights from more than 28,000 heavy opioid users.”
Dr. Palmer is a co-author on “Comparison of Deep Learning Tools for Optic Nerve Axon Quantification Finds Limited Generalizability Upon Independent Validation,” which was recently published in Bioengineering.
The manuscript titled “Genome-wide association study of cocaine self-administration behavior in Heterogeneous Stock rats” was accepted for publication in Nature Communications.
Authors include current and past* Palmer Lab members Montana Lara, Thiago Sanches, Oksana Polesskaya, Denghui Chen, Riyan Cheng, Apurva Chitre, Benjamin Johnson, Elaine Keung*, Khai Nguyen*, and Abraham Palmer.
Congratulations!

Professor & Vice Chair for Basic Research,
Department of Psychiatry
University of California San Diego
Director,
NIDA Center of Excellence for Genetics, Genomics, and Epigenetics of Substance Use Disorders in Outbred Rats
________________________
La Jolla, CA 92093-0667
________________________
Email: aap@ucsd.edu
Phone: (858) 534-2093
Twitter: @AbePalmer
UCSD Profile
________________________
PhD, Biomedical Sciences
University of California San Diego, 1999
BA, Biology
University of Chicago, 1992

